Literature DB >> 32835785

Classical and novel GH receptor signaling pathways.

Stuart J Frank1.   

Abstract

In this review, I summarize historical and recent features of the classical pathways activated by growth hormone (GH) through the cell surface GH receptor (GHR). GHR is a cytokine receptor superfamily member that signals by activating the non-receptor tyrosine kinase, JAK2, and members of the Src family kinases. Activation of the GHR engages STATs, PI3K, and ERK pathways, among others, and details of these now-classical pathways are presented. Modulating elements, including the SOCS proteins, phosphatases, and regulated GHR metalloproteolysis, are discussed. In addition, a novel physical and functional interaction of GHR with IGF-1R is summarized and discussed in terms of its mechanisms, consequences, and physiological and therapeutic implications.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Growth hormone receptor; IGF-1 receptor; Signaling

Mesh:

Substances:

Year:  2020        PMID: 32835785      PMCID: PMC7799394          DOI: 10.1016/j.mce.2020.110999

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  221 in total

1.  The role of endotoxin, TNF-alpha, and IL-6 in inducing the state of growth hormone insensitivity.

Authors:  Ping Wang; Ning Li; Jie-Shou Li; Wei-Qin Li
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

2.  Rational design of potent antagonists to the human growth hormone receptor.

Authors:  G Fuh; B C Cunningham; R Fukunaga; S Nagata; D V Goeddel; J A Wells
Journal:  Science       Date:  1992-06-19       Impact factor: 47.728

3.  A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells.

Authors:  R A Black; C T Rauch; C J Kozlosky; J J Peschon; J L Slack; M F Wolfson; B J Castner; K L Stocking; P Reddy; S Srinivasan; N Nelson; N Boiani; K A Schooley; M Gerhart; R Davis; J N Fitzner; R S Johnson; R J Paxton; C J March; D P Cerretti
Journal:  Nature       Date:  1997-02-20       Impact factor: 49.962

4.  The structure of human STAT5A and B genes reveals two regions of nearly identical sequence and an alternative tissue specific STAT5B promoter.

Authors:  Raffaele Ambrosio; Giorgia Fimiani; Jlenia Monfregola; Emma Sanzari; Nicola De Felice; Maria Carolina Salerno; Claudio Pignata; Michele D'Urso; Matilde Valeria Ursini
Journal:  Gene       Date:  2002-02-20       Impact factor: 3.688

5.  Gigantism in mice lacking suppressor of cytokine signalling-2.

Authors:  D Metcalf; C J Greenhalgh; E Viney; T A Willson; R Starr; N A Nicola; D J Hilton; W S Alexander
Journal:  Nature       Date:  2000-06-29       Impact factor: 49.962

6.  Normal growth and development in the absence of hepatic insulin-like growth factor I.

Authors:  S Yakar; J L Liu; B Stannard; A Butler; D Accili; B Sauer; D LeRoith
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

7.  Activation of acute phase response factor (APRF)/Stat3 transcription factor by growth hormone.

Authors:  G S Campbell; D J Meyer; R Raz; D E Levy; J Schwartz; C Carter-Su
Journal:  J Biol Chem       Date:  1995-02-24       Impact factor: 5.157

8.  Identification of a JAK2-independent pathway regulating growth hormone (GH)-stimulated p44/42 mitogen-activated protein kinase activity. GH activation of Ral and phospholipase D is Src-dependent.

Authors:  Tao Zhu; Ling Ling; Peter E Lobie
Journal:  J Biol Chem       Date:  2002-09-05       Impact factor: 5.157

9.  Grb10 identified as a potential regulator of growth hormone (GH) signaling by cloning of GH receptor target proteins.

Authors:  S Moutoussamy; F Renaudie; F Lago; P A Kelly; J Finidori
Journal:  J Biol Chem       Date:  1998-06-26       Impact factor: 5.157

10.  The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.

Authors:  L S Smit; D J Meyer; N Billestrup; G Norstedt; J Schwartz; C Carter-Su
Journal:  Mol Endocrinol       Date:  1996-05
View more
  5 in total

Review 1.  Prolactin: The Third Hormone in Breast Cancer.

Authors:  Linda A Schuler; Kathleen A O'Leary
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-16       Impact factor: 6.055

2.  Constitutively Active STAT5b Feminizes Mouse Liver Gene Expression.

Authors:  Dana Lau-Corona; Hong Ma; Cameron Vergato; Andre Sarmento-Cabral; Mercedes Del Rio-Moreno; Rhonda D Kineman; David J Waxman
Journal:  Endocrinology       Date:  2022-05-01       Impact factor: 5.051

Review 3.  Growth Hormone Receptor Regulation in Cancer and Chronic Diseases.

Authors:  Ger J Strous; Ana Da Silva Almeida; Joyce Putters; Julia Schantl; Magdalena Sedek; Johan A Slotman; Tobias Nespital; Gerco C Hassink; Jan A Mol
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-18       Impact factor: 5.555

4.  A novel peptide antagonist of the human growth hormone receptor.

Authors:  Reetobrata Basu; Khairun Nahar; Prateek Kulkarni; Olivia Kerekes; Maya Sattler; Zachary Hall; Sebastian Neggers; Justin M Holub; John J Kopchick
Journal:  J Biol Chem       Date:  2021-03-24       Impact factor: 5.157

Review 5.  Towards Understanding the Direct and Indirect Actions of Growth Hormone in Controlling Hepatocyte Carbohydrate and Lipid Metabolism.

Authors:  Mari C Vázquez-Borrego; Mercedes Del Rio-Moreno; Rhonda D Kineman
Journal:  Cells       Date:  2021-09-24       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.